Basic Principles of Pharmacology Flashcards

1
Q

Pharmacokinetics describes…

A

the relationship between drug
dose and drug concentration in plasma or at the site of drug
effect over time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What processes make up pharmacokinetics?

A

Absorption, distribution and elimination (metabolism and excrection)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the volume od distribution? How to calculate?

A

The volume of distribution (Vd) is the apparen size of the tank in which a known amount of drug distributes to produce a measured drug concentration once the drug has had enough time to thoroughly mix within the tank.

Volume of distribution = Amount of dose (t) / Concentration (t)

(t) = at a given time

Usually in mg/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

If drug elimination occurs as a first-order process (i.e.,
elimination is proportional to the concentration at that
time), in a tank model, the volume of distribution calculated by will be … over time

A

constant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

The more soluble a drug is in peripheral tissue relative to blood or plasma, the … the peripheral volumes of distribution

A

larger

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Clearence describes …

A

the rate of drug removal from the
plasma/blood, is defined as the volume of plasma cleared of a drug over a specified time period

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is systemic clearence? And intercompartimental clearence?

A

Systemic clearance permanently removes drug from the body, either by eliminating the parent molecule or by transforming it into
metabolites.

Intercompartmental clearance moves drug
between plasma and peripheral tissue tanks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the difference between clearence and elimination rate?

A

Clearance is defined in units of flow, that is, the volume completely cleared of drug per unit of time (e.g., L/min).

Clearance is not to be confused with elimination rate (e.g., mg/min).

The elimination rate is not an accurate method of describing the mass of drug removed over time. For example, assuming a first-order process, when plasma concentrations are high, the rate of drug elimination is high. When low, the rate is also low.

Clearance is a better descriptor as it is independent of drug concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How clearance can be calculated at the steady state during a continuous infusion?

A

Clearance= Infusion rate / Css

Css is the plasma concentration at steady state

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How the the first-order elimination rate constant can be calculated?

A

K = CL / Vd

Where CL is clearance with units of volume/time (L/min), Vd is the compartment distribution volume with units of liters (L),

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

In a physiologic model of clearance, how the total clearance can be obtained?

A

The total clearance is the sum of each clearance by metabolic organs such as the liver, kidney, and other tissues

To calculate a metabolic organ clearance:

Clearance= Q (Cin −Cout) / Cin

  • Q is the blood flow to metabolic organs;
  • Cin is the concentration of drug delivered to metabolic organs;
  • Cout is the concentration of drug leaving metabolic organs

Obs: The fraction of inflowing drug extracted by the organ [ (Cin−Cout) / Cin ] is called the extraction ratio (ER), so:

Clearance = Q x ER

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the relation between hepatic extraction ratio (ER), blood flow and drug metabolism

A
  • For drugs with an ER of nearly 1 (e.g., propofol), a change in liver blood flow produces a nearly
    proportional change in clearance.
    If nearly 100% of the drug is extracted by
    the liver, this implies that the liver has a very large metabolic capacity for the drug. In this case, the rate-limiting step in metabolism is the flow of drug to the liver, and such drugs are
    said to be “flow limited.” As a consequence, any reduction in liver blood flow due to circulatory effects of anesthetic agents or changes in circulatory volumes in cases of perioperative bleeding or other situations of excessive fluid loss can be expected to reduce liver-dependent drug clearance.
  • For drugs with a low ER (e.g., alfentanil), clearance is nearly independent of the rate
    of liver blood flow.
    For these drugs, clearance is limited by
    the capacity of the liver to take up and metabolize drug. These drugs are said to be “capacity limited.” Clearance will change in response to any change in the capacity of
    the liver to metabolize such drugs, as might be caused by liver disease or enzymatic induction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the zero and the first order kinetics?

A

With zero-order kinetics, drug is eliminated at a constant rate, regardless of the plasma concentration, following a linear elimination phase as the system becomes saturated.
A simple analogy would be an athlete signing an autograph on a picture. Regardless of the total amount of photographs that must be signed, the athlete can only sign one autograph every 15 seconds. The rate-limiting factor of this analogy and zero-order kinetics is time.

With first-order kinetics, drug is eliminated at a rate proportional to the amount of drug
present at that time.
To utilize the same analogy, now the entire team can sign the photographs. The more hotographs there are to sign, the more athletes can sign. The rate-limiting factor of this analogy and in first-order kinetics is the initial concentration

  • In the case of the autographs, if the amount of needed autographed photos exceeds the number of available athletes, the first-order elimination then becomes zero-order
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How to calculate de elimination half-life of a drug with first-order kinetic from a compartment?

A

t1/2 = 0.693 / k

k is the first-order kinetic elimination rate constant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Front-end kinetics

A

Front-end kinetics refers to the description of intravenous drug behavior immediately following administration.

  • How a drug rapidly moves from the blood into peripheral tissues directly influences the peak plasma drug concentration.
    The amount of drug that moves to the peripheral tissue commonly surpasses the amount that is eliminated during the first few minutes after drug administration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Back-end kinetics

A

Back-end kinetics provides descriptors of how plasma drug concentrations decrease once a continuous infusion is terminated. An example is decrement time, which predicts the time required to reach a certain plasma concentration once an infusion is terminated. Decrement times are a function of infusion duration

17
Q

Hysteresis refers to

A

Hysteresis refers to the time delay between changes in plasma concentration and drug effect. Hysteresis accounts for the time required for drug to diffuse from the plasma to the site of action plus the time required, once drug is at the
site of action, to elicit a drug effect.

This lag between the plasma concentration and effect usually results in the phenomenon called hysteresis in which two different plasma concentrations correspond to one drug effect or one plasma concentration corresponds to
two drug effects

18
Q

Kinetic micro rate constants used to describe biophase include k1e and ke0. The k1e describes …, and ke0 describe the …

A

drug movement from the central compartment to the effect site

elimination of drug from the effect-site compartment

19
Q

To create a pharmacodynamic model, the hysteresis loop is collapsed using modeling techniques that account for the lag time between plasma concentrations and the observed effect. These modeling techniques provide an estimate of the lag time, known as the…, and an estimate of the effectsite concentration (CE) associated with a 50% probability of drug effect (C50).

A

t1/2ke0

20
Q

Most concentration effect relationships in anesthesia are described with a sigmoid curve. The standard equation for this relationship is the “Hill Equation,” also known as the “sigmoid Emax relationship”:

Effect=E0 + (Emax −E0) * (C^g/(C50^g +C^g))

  • E0 is the baseline effect
  • Emax is the maximal effect,
  • C is the drug concentration
  • γ or g (gamma) represents the slope of the concentration-effect relationship.

Gamma (γ) is also known as the “Hill coefficient.” For values of γ < 1, the curve is …; for values of γ > 1, the curve is …

Obs: ^ is used to denote coefficient

A

hyperbolic

sigmoid

21
Q

Potency describes …

A

the amount of drug required to elicit an effect. The C50 is a common parameter used to describe potency

22
Q

For drugs that have a concentration-versus-effect relationship that is shifted to the
left (small C50), the drug is considered to be … potent;
For drugs that have a concentrationversus-effect relationship shifted to the right, the drug is considered to be … potent.

A

more

less

23
Q

Efficacy is …

A

a measure of drug effectiveness at producing an effect once it occupies a receptor. Similar drugs
that work through the same receptor may have varying degrees of effect despite having the same receptor occupancy

24
Q

Describe the dynamic range

A

the concentration range where changes in concentration lead to a change in effect

  • Concentrations outside the dynamic range do not yield much change in drug effect
25
Q

The therapeutic index of a drug is defined as the ratio between the LD50 and the ED50

A

ratio between the LD50 and the ED50

  • ED50 is the dose at which there is a 50% probability of effect
  • LD50 is the dose with a 50% probability of death
26
Q

A term used to characterize the continuum of drug concentrations across various combinations of drug pairs (X in combination with Y) is the …

A

isobole

27
Q

A common isobole is the 50% isobole line. It represents …

A

all possible combinations of two-drug effect-site concentrations that would lead to a 50% probability of a given effect

  • Other isoboles are of more clinical interest. For example, the 95% isobole for loss of responsiveness represents the concentration pairs necessary to ensure a 95% probability of unresponsiveness
28
Q

Additive isoboles are lines connecting equi-effective concentrations CX and VY of the agents X and Y.
Subadditive effects (antagonism) are indicated by … and superadditive (synergism) effects by …

A

elliptical isoboles located above the additivity line

hyperbolic isoboles located below the additivity line

29
Q

Hendrickx and colleagues surveyed the literature for work in both humans and animal models that described anesthetic drug interactions for opioids, sedative hypnotics, and inhalation agents.
They found several interesting features of anesthetic drug combinations.
First, inhalation agents when combined are strictly 1…, suggesting a common mechanism of action, except for 2…, which has an infra-additive interaction with other inhalation agents.

Second, interactions between various
intravenous drugs and inhalation agents are 3… except for 4…

Third, interactions between different classes of intravenous drugs (e.g., opioids and sedative hypnotics) are primarily 5…, except for 6…

A

1) additive

2) nitrous oxide

3) synergistic

4) nitrous oxide and GABA sedative hypnotics

5) synergistic

6) ketamine and benzodiazepines

30
Q

The douse of propfol in obese patients should be adjusted. Of the many available dosing scalars, authors recommend … for bolus dosing (i.e., during induction) and … for infusions

A

LBM (lean body mass)

TBW (total body weight) or CBW (corrected body weight)

  • Obs: CBW for infusions may underdose
31
Q

In obese patients, although not clinically validated, Greenblatt and associates recommend that bolus doses of midazolam should be scaled to … and other dosing scalars may lead to inadequate effect. On the other hand, with a fixed elimination, continuous infusion rates should be dosed to …

A

TBW

IBW

32
Q

Studies suggest that dosing of dexmedetomidine, which is calculated using
TBW, can be … in obese patients

A

overdosing

33
Q

For an obese patient, dosing scaled to … resulted in almost identical remifentanil effect-site concentrations as in the lean patient dosed according to TBW.

Dosing scaled to LBM in the obese individual resulted in … effect-site concentrations than those in a lean individual dosed according to TBW

A

FFM (fat free mass)

lower

34
Q

Morphine dose adjsutment in obese

A

de Hoogd and colleagues performed a population pharmacokinetic analysis of intravenous morphine in morbidly obese individuals. They found that morphine
pharmacokinetics were comparable to those of healthy volunteers. They concluded that no weight-based dosing adjustments were necessary. However, they also found
that the elimination of pharmacologically active metabolite was decreased, resulting in an increased exposure to active metabolite with prolonged administrations. They concluded that the clinical relevance of this phenomenon
was not clear